Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Operating Expenses (2020 - 2025)

Historic Operating Expenses for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $2.9 million.

  • iSpecimen's Operating Expenses fell 3275.51% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.5 million, marking a year-over-year decrease of 2315.75%. This contributed to the annual value of $22.0 million for FY2024, which is 436.84% up from last year.
  • iSpecimen's Operating Expenses amounted to $2.9 million in Q3 2025, which was down 3275.51% from $2.5 million recorded in Q2 2025.
  • iSpecimen's Operating Expenses' 5-year high stood at $7.3 million during Q4 2024, with a 5-year trough of $2.5 million in Q2 2025.
  • For the 5-year period, iSpecimen's Operating Expenses averaged around $4.7 million, with its median value being $4.9 million (2022).
  • As far as peak fluctuations go, iSpecimen's Operating Expenses surged by 14494.19% in 2021, and later plummeted by 4976.44% in 2025.
  • iSpecimen's Operating Expenses (Quarter) stood at $4.5 million in 2021, then rose by 12.3% to $5.1 million in 2022, then rose by 6.72% to $5.4 million in 2023, then surged by 34.33% to $7.3 million in 2024, then tumbled by 59.86% to $2.9 million in 2025.
  • Its Operating Expenses stands at $2.9 million for Q3 2025, versus $2.5 million for Q2 2025 and $2.7 million for Q1 2025.